Andreas Hochhaus - Concepedia

Author

Andreas Hochhaus

Also Known As

A Hochhaus, A. Hochhaus, A., Hochhaus, ANDREAS HOCHHAUS, Aladdin Ali-Deeb, Andreas Hochhaus, Andreas Neubauer, Arlene Reisman, B. Eichhorst, Chuah, C.

1.6K

Publications

89.6K

Citations

128

H-Index

234

Concepts

All Affiliations

Jena University Hospital Heidelberg University The University of Texas MD Anderson Cancer Center University Hospital Heidelberg Charité - Universitätsmedizin Berlin

About

Andreas Hochhaus is an author at Jena University Hospital specializing in medicine, oncology, and hematology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	64	197	17K
2	Health Sciences	35	74	7.3K
3	Engineering	11	11	900
4	Education	2	2	97
5	Arts	1	1	20

Andreas Hochhaus

556

Publications

66.1K

Citations

116

H-Index

Page 1

	Year	Citations
Imatinib Compared with Interferon and Low-Dose Cytarabine for Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Stephen G. O’Brien, François Guilhot, Richard A. Larson, New England Journal of Medicine	2003	3.5K
Five-Year Follow-up of Patients Receiving Imatinib for Chronic Myeloid Leukemia Brian Druker, François Guilhot, Stephen G. O’Brien, New England Journal of Medicine	2006	3.5K
Hematologic and Cytogenetic Responses to Imatinib Mesylate in Chronic Myelogenous Leukemia Hagop Kantarjian, Charles L. Sawyers, Andreas Hochhaus, New England Journal of Medicine	2002	2K
Adjuvant Chemotherapy With Gemcitabine and Long-term Outcomes Among Patients With Resected Pancreatic Cancer Helmut Oettle, P. Neuhaus, Andreas Hochhaus, JAMA	2013	1.8K
Nilotinib versus Imatinib for Newly Diagnosed Chronic Myeloid Leukemia Giuseppe Saglio, Dong‐Wook Kim, Surapol Issaragrisil, New England Journal of Medicine	2010	1.7K
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Hagop M. Kantarjian, Neil P. Shah, Andreas Hochhaus, New England Journal of Medicine	2010	1.6K
Nilotinib in Imatinib-Resistant CML and Philadelphia Chromosome–Positive ALL Hagop M. Kantarjian, Francis J. Giles, Lydia Wunderle, New England Journal of Medicine	2006	1.3K
Frequency of Major Molecular Responses to Imatinib or Interferon Alfa plus Cytarabine in Newly Diagnosed Chronic Myeloid Leukemia Timothy P. Hughes, Jaspal Kaeda, Susan Branford, New England Journal of Medicine	2003	1.2K
Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia Andreas Hochhaus, Richard A. Larson, François Guilhot, New England Journal of Medicine	2017	1.2K
Inactivating mutations of the histone methyltransferase gene EZH2 in myeloid disorders Thomas Ernst, Andrew Chase, Joannah Score, Nature Genetics Histone ModificationsChromatinChromatin RemodelingEpigenetic ChangeGenetics	2010	1.1K

Page 1